127 related articles for article (PubMed ID: 21426089)
1. Gallium (III) triflate-catalyzed synthesis of heterocycles: quinoxalines, 1,5-benzodiazepines and their fluorinated derivatives.
Prakash GK; Vaghoo H; Venkat A; Panja C; Chacko S; Mathew T; Olah GA
Future Med Chem; 2009 Aug; 1(5):909-20. PubMed ID: 21426089
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors.
Xu B; Sun Y; Guo Y; Cao Y; Yu T
Bioorg Med Chem; 2009 Apr; 17(7):2767-74. PubMed ID: 19269831
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives.
Font M; Monge A; Alvarez E; Cuartero A; Losa MJ; Fidalgo MJ; SanMartín C; Nadal E; Ruiz I; Merino I; Martínez-Irujo JJ; Alberdi E; Santiago E; Prieto I; Lasarte JJ; Sarobe P; Borrás F
Drug Des Discov; 1997 Apr; 14(4):305-32. PubMed ID: 9197981
[TBL] [Abstract][Full Text] [Related]
4. 1,5-Benzodiazepines. Part XII. Synthesis and biological evaluation of tricyclic and tetracyclic 1,5-benzodiazepine derivatives as nevirapine analogues.
Di Braccio M; Grossi G; Roma G; Vargiu L; Mura M; Marongiu ME
Eur J Med Chem; 2001; 36(11-12):935-49. PubMed ID: 11755236
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and study of anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives.
Chander S; Tang CR; Al-Maqtari HM; Jamalis J; Penta A; Hadda TB; Sirat HM; Zheng YT; Sankaranarayanan M
Bioorg Chem; 2017 Jun; 72():74-79. PubMed ID: 28371664
[TBL] [Abstract][Full Text] [Related]
6. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2009 Apr; 6(4):561-8. PubMed ID: 19353537
[TBL] [Abstract][Full Text] [Related]
7. Thiourea-based non-nucleoside inhibitors of HIV reverse transcriptase as bifunctional organocatalysts in the asymmetric Strecker synthesis.
Tsogoeva SB; Hateley MJ; Yalalov DA; Meindl K; Weckbecker C; Huthmacher K
Bioorg Med Chem; 2005 Oct; 13(19):5680-5. PubMed ID: 15964195
[TBL] [Abstract][Full Text] [Related]
8. Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.
Li D; Zhan P; De Clercq E; Liu X
J Med Chem; 2012 Apr; 55(8):3595-613. PubMed ID: 22268494
[No Abstract] [Full Text] [Related]
9. Synthesis and anti-HIV-1 activity of novel 2,3-dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones.
Danel K; Pedersen EB; Nielsen C
J Med Chem; 1998 Jan; 41(2):191-8. PubMed ID: 9457243
[TBL] [Abstract][Full Text] [Related]
10. Search for new non-nucleoside inhibitors of HIV-1 reverse transcriptase (HIV-1 RT).
Brzezińska E; Glinka R
Acta Pol Pharm; 2002; 59(5):379-86. PubMed ID: 12602800
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors.
Patel M; McHugh RJ; Cordova BC; Klabe RM; Erickson-Viitanen S; Trainor GL; Rodgers JD
Bioorg Med Chem Lett; 2000 Aug; 10(15):1729-31. PubMed ID: 10937734
[TBL] [Abstract][Full Text] [Related]
12. Multiple weak intercalation as a strategy for the inhibition of polymerases.
Jain N; Friedman SH
Bioorg Med Chem Lett; 2019 Feb; 29(3):424-429. PubMed ID: 30579791
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Ma XD; Zhang X; Dai HF; Yang SQ; Yang LM; Gu SX; Zheng YT; He QQ; Chen FE
Bioorg Med Chem; 2011 Aug; 19(15):4601-7. PubMed ID: 21719299
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
Wang Z; Vince R
Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase.
Gomez R; Jolly S; Williams T; Tucker T; Tynebor R; Vacca J; McGaughey G; Lai MT; Felock P; Munshi V; DeStefano D; Touch S; Miller M; Yan Y; Sanchez R; Liang Y; Paton B; Wan BL; Anthony N
Bioorg Med Chem Lett; 2011 Dec; 21(24):7344-50. PubMed ID: 22071300
[TBL] [Abstract][Full Text] [Related]
16. Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Boyer J; Arnoult E; Médebielle M; Guillemont J; Unge J; Jochmans D
J Med Chem; 2011 Dec; 54(23):7974-85. PubMed ID: 22017513
[TBL] [Abstract][Full Text] [Related]
17. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
[TBL] [Abstract][Full Text] [Related]
20. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
